Common SPINK-1 mutations do not predispose to the development of non-alcoholic fatty liver disease
Background: Non-alcoholic fatty liver disease (NAFLD) is common in obese and diabetics. Serine protease inhibitor Kazal-1 (SPINK-1) protein is highly expressed in the liver and adipose tissue of diabetic and obese suggesting its role in NAFLD. SPINK-1 also behaves as an acute phase reactant protein....
Main Authors: | Nevin Oruc;, Omer Ozutemiz;, Ulus Salih Akarca;, Afig Berdeli;, Galip Ersoz;, Fulya Gunsar;, Zeki Karasu;, Tankut Ilter;, Yucel Batur |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2009-04-01
|
Series: | Annals of Hepatology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1665268119317880 |
Similar Items
-
Serum procalcitonin and CRP levels in non-alcoholic fatty liver disease: a case control study
by: Ersoz Galip, et al.
Published: (2009-02-01) -
Role of intrapancreatic SPINK1/Spink3 expression in the development of pancreatitis
by: Masaki eOhmuraya, et al.
Published: (2012-05-01) -
Functional Roles of SPINK1 in Cancers
by: Tsung-Chieh Lin
Published: (2021-04-01) -
Downregulated SPINK4 is associated with poor survival in colorectal cancer
by: Xiaojie Wang, et al.
Published: (2019-12-01) -
SPINKs in Tumors: Potential Therapeutic Targets
by: Chengcheng Liao, et al.
Published: (2022-02-01)